14-day treatment for H. pylori infection
This trial tests a 14-day treatment using two medicines, vonoprazan and minocycline, to get rid of an H. pylori infection in the stomach. It aims to see if this combination is safe and works well, and might be a simpler option for people who haven't been treated for H. pylori before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have an active H. pylori infection, confirmed by a breath test or other tests.
- You have never been treated for H. pylori before.
- You do not have severe liver, kidney, or other serious health problems.
- You are not pregnant or breastfeeding.
- You have not taken antibiotics or bismuth in the last month, or acid-reducing drugs in the last 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatments for an H. pylori stomach infection: taking two medicines (vonoprazan and amoxicillin) versus taking four medicines. Both treatments are given for 14 days.
This trial compares different lengths of treatment with two or four medications to see which works best for clearing H. pylori, a stomach bacteria that can cause ulcers. It is for people who have not been treated for this infection before.
This trial tests whether a new type of acid-reducing drug (vonoprazan) works better than a common one (proton pump inhibitor) when combined with vitamin D or probiotics to clear H. pylori, a bacteria that can cause stomach problems. If you have H. pylori and haven't been treated for it before, this study may be for you.
This trial tests a new combination of medicines to treat H. pylori infection that has not gone away after at least two previous treatments. It may help if you have not had success with standard therapy and are looking for another option.
This trial tests a 14-day treatment using bismuth, amoxicillin, and a stomach acid reducer (PCAB) to see how well it clears H. pylori, a bacteria that can cause stomach ulcers. It may be an option if you have H. pylori and haven't had stomach surgery or certain serious health conditions.
This study tests a new combination of medicines to treat H. pylori, a common stomach infection that can cause ulcers. The goal is to see if a stronger acid-reducing approach helps the treatment work better.
Hear when a new HELICOBACTER PYLORI INFECTIONS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.